Range Low Price High Price Comment
30 days $0.371 $0.93 Wednesday, 1st May 2024 SNGX stock ended at $0.396. This is 1.54% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 5.08% from a day low at $0.390 to a day high of $0.410.
90 days $0.371 $0.93
52 weeks $0.371 $4.20

Historical Soligenix, Inc prices

Date Open High Low Close Volume
May 20, 2016 $0.630 $0.688 $0.630 $0.688 55 000
May 19, 2016 $0.680 $0.690 $0.630 $0.680 29 100
May 18, 2016 $0.670 $0.680 $0.670 $0.680 21 000
May 17, 2016 $0.701 $0.720 $0.640 $0.685 112 500
May 16, 2016 $0.730 $0.758 $0.700 $0.719 60 900
May 13, 2016 $0.745 $0.790 $0.730 $0.760 36 500
May 12, 2016 $0.785 $0.785 $0.730 $0.750 35 600
May 11, 2016 $0.760 $0.80 $0.740 $0.770 61 400
May 10, 2016 $0.750 $0.81 $0.750 $0.81 35 800
May 09, 2016 $0.84 $0.84 $0.770 $0.82 16 500
May 06, 2016 $0.790 $0.85 $0.760 $0.84 66 800
May 05, 2016 $0.83 $0.85 $0.790 $0.84 37 500
May 04, 2016 $0.85 $0.90 $0.81 $0.82 27 000
May 03, 2016 $0.795 $0.90 $0.795 $0.86 29 700
May 02, 2016 $0.81 $0.89 $0.770 $0.87 172 400
Apr 29, 2016 $0.780 $0.780 $0.702 $0.770 67 100
Apr 28, 2016 $0.766 $0.779 $0.730 $0.779 47 500
Apr 27, 2016 $0.765 $0.765 $0.720 $0.741 58 700
Apr 26, 2016 $0.790 $0.790 $0.750 $0.777 38 700
Apr 25, 2016 $0.82 $0.82 $0.760 $0.760 34 700
Click to get the best stock tips daily for free!

About Soligenix, Inc

Soligenix Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has completed Phase III clinical trial for the treatment of treat cutaneous T-cell lymphoma; and SGX942, an ... SNGX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT